All Releases
 |
Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
Mar 8, 2010
|
15.0 KB |
| |
REDWOOD CITY, Calif., March 8, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of positive results from a large international study which demonstrated that the Oncotype DX(R) breast cancer Recurrence Score(R) (RS) result is a significant independent predictor of distant recurrence in ...
|
 |
Genomic Health Develops New Methods for Whole Genome Expression Analysis of Standard Pathology Tumor Specimens
Mar 1, 2010
|
12.8 KB |
| |
REDWOOD CITY, Calif., March 1, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that its research scientists have developed a clinically useful method for whole genome expression analysis using standard tumor specimens that are routinely collected in clinical practice. Genomic Health is now able to a...
|
 |
Genomic Health Announces Analysis Reinforcing Clinical Utility of Oncotype DX(R) Breast Cancer Test in Asia Pacific Patient Population
Feb 26, 2010
|
12.4 KB |
| |
REDWOOD CITY, CA and KYOTO, JAPAN, Feb 26, 2010 (MARKETWIRE via COMTEX News Network) -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from an analysis demonstrating that the Oncotype DX(R) breast cancer test has similar clinical relevance in estrogen receptor-positive, early-stage breast cancer patients in Asia Pacific (AP) countries ...
|
 |
Genomic Health Announces Year-End 2009 Financial Results
Feb 3, 2010
|
20.7 KB |
| |
REDWOOD CITY, Calif., Feb 03, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results for the year ended December 31, 2009, which included 35 percent revenue growth compared with 2008, and the company becoming cash flow positive.
Total revenue for the fourth quarter of 2009 increased to $3...
|
 |
Genomic Health to Announce Fourth Quarter and Year-End 2009 Financial Results and Host Conference Call on Wednesday, February 3
Jan 27, 2010
|
8.1 KB |
| |
REDWOOD CITY, Calif., Jan 27, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, February 3 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2009 financial results. The call and webcast will follow the release of...
|
 |
Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test
Jan 21, 2010
|
13.6 KB |
| |
REDWOOD CITY, Calif., Jan 21, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced worldwide commercial availability of its Oncotype DX(R) colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. The 12-gene advanced dia...
|
 |
Genomic Health Announces Publication of Data Demonstrating that the Oncotype DX(R) Breast Cancer Test Significantly Influences Breast Cancer Treatment Decisions, While Increasing Physician Confidence and Patient Satisfaction
Jan 12, 2010
|
19.9 KB |
| |
REDWOOD CITY, Calif., Jan 12, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of a prospective, multi-center, study that showed the Oncotype DX(R) breast cancer test Recurrence Score(R) had a significant impact on breast cancer treatment decisions for early-stage breast cancer patient...
|
 |
Genomic Health Announces Preliminary Q4 and 2009 Revenue
Jan 7, 2010
|
9.0 KB |
| |
REDWOOD CITY, Calif., Jan 07, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it expects to meet its 2009 annual revenue guidance. Preliminary total revenue for the year ended December 31, 2009 is expected to be $149.5 million, compared with $110.6 million in 2008, representing an increase of ...
|
 |
Genomic Health to Present at J.P. Morgan Healthcare Conference
Jan 4, 2010
|
8.6 KB |
| |
REDWOOD CITY, Calif., Jan 04, 2010 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's Chief Executive Officer, will present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11 at 4 p.m. Pacific Time.
To access the live and...
|
 |
Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX® in Multiple Breast Cancer Populations
Dec 15, 2009
|
17.9 KB |
| |
REDWOOD CITY, CA, Dec 15, 2009 (MARKETWIRE via COMTEX News Network) -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from five new studies on its Oncotype DX(R) breast cancer test, a multi-gene expression test that physicians currently use to predict the likelihood of chemotherapy benefit and recurrence risk for patients with early-st...
|
 |
Genomic Health Announces Results of Clinical Survey Showing Use of Oncotype DX(R) Changes Treatment Recommendations for Women With Lymph Node-Positive Breast Cancer, Leading to Overall Reduction in Chemotherapy
Dec 11, 2009
|
12.6 KB |
| |
SAN ANTONIO, Dec 11, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from a clinical survey evaluating the impact of the Oncotype DX(R) Recurrence Score(R) result on physicians' adjuvant treatment recommendations for patients with node-positive, hormone receptor-positive breast canc...
|
 |
Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
Dec 10, 2009
|
13.8 KB |
| |
SAN ANTONIO, Dec 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that The Lancet Oncology published positive results from a study of Oncotype DX((R)) in postmenopausal women with node-positive, estrogen receptor-positive breast cancer conducted by the Southwest Oncology Group (SWOG), a ...
|
 |
Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium
Dec 4, 2009
|
13.3 KB |
| |
REDWOOD CITY, Calif., Dec 04, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from five studies at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS), taking place December 9-13, 2009, at the Henry B. Gonzalez Convention Center. Four of the st...
|
 |
Genomic Health to Present at Piper Jaffray Health Care Conference
Nov 24, 2009
|
8.6 KB |
| |
REDWOOD CITY, Calif., Nov 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Genomic Health's Executive Chairman, will present at the 21st Annual Piper Jaffray Health Care Conference in New York City on Tuesday, December 1, 2009 at 10:00 a.m. ET.
To access the live and s...
|
 |
Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress
Nov 4, 2009
|
18.5 KB |
| |
REDWOOD CITY, Calif., Nov 04, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2009.
Total revenue increased to $39.5 million in the third quarter of 2009 compared with $28.1 million in the third quarter of 2008. Pr...
|
 |
Genomic Health to Announce Third Quarter 2009 Financial Results and Host Conference Call on Wednesday, November 4, 2009
Oct 28, 2009
|
10.2 KB |
| |
REDWOOD CITY, Calif., Oct 28, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, November 4, 2009 at 4:30 p.m. Eastern Time (ET) to discuss its third quarter 2009 financial results. The call and webcast will follow the rele...
|
 |
Genomic Health Announces Analyst Day Webcast Presentation to be Held on November 12, 2009
Oct 23, 2009
|
9.0 KB |
| |
SAN FRANCISCO, Oct 23, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health (Nasdaq: GHDX) today announced that the Company will hold a business and scientific briefing on Thursday, November 12, 2009 beginning at 12:30 p.m. ET in New York City.
Members of Genomic Health's management team will discuss how the company is breaking ba...
|
 |
Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients
Oct 9, 2009
|
12.8 KB |
| |
SAN FRANCISCO, Oct 09, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer te...
|
 |
Breastcancer.org Joins My Breast Cancer Coach to Provide Newly Diagnosed Patients With Online Personalized Treatment Information
Oct 8, 2009
|
18.3 KB |
| |
REDWOOD CITY, CA - October 8, 2009 - Breastcancer.org has joined with Genomic Health, Inc. and Breast Cancer Network of Strength to expand My Breast Cancer Coach, a uni...
|
 |
Genomic Health to Present Studies at the American Society of Clinical Oncology 2009 Breast Cancer Symposium
Oct 6, 2009
|
10.7 KB |
| |
REDWOOD CITY, Calif., Oct 06, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from two studies at the American Society of Clinical Oncology (ASCO) 2009 Breast Cancer Symposium, taking place October 8 through October 10 at the San Francisco Marriott in S...
|
|
|